Geode Capital Management’s Ensysce Biosciences ENSC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7K | Buy |
+10,161
| New | +$22.7K | ﹤0.01% | 4348 |
|
|
2024
Q4 | – | Sell |
-46,072
| Closed | -$11.1K | – | 4484 |
|
|
2024
Q3 | $11.1K | Sell |
46,072
-29
| -0.1% | -$7 | ﹤0.01% | 4464 |
|
|
2024
Q2 | $23.3K | Buy |
46,101
+27,783
| +152% | +$14.1K | ﹤0.01% | 4427 |
|
|
2024
Q1 | $14.5K | Buy |
18,318
+2,037
| +13% | +$1.61K | ﹤0.01% | 4518 |
|
|
2023
Q4 | $17K | Sell |
16,281
-149
| -0.9% | -$156 | ﹤0.01% | 4539 |
|
|
2023
Q3 | $22.5K | Buy |
+16,430
| New | +$22.5K | ﹤0.01% | 4600 |
|
|
2022
Q4 | – | Sell |
-130,523
| Closed | -$28K | – | 4907 |
|
|
2022
Q3 | $28K | Buy |
130,523
+3,175
| +2% | +$681 | ﹤0.01% | 4859 |
|
|
2022
Q2 | $110K | Buy |
127,348
+17,102
| +16% | +$14.8K | ﹤0.01% | 4552 |
|
|
2022
Q1 | $125K | Buy |
110,246
+9,325
| +9% | +$10.6K | ﹤0.01% | 4572 |
|
|
2021
Q4 | $474K | Buy |
100,921
+45,991
| +84% | +$216K | ﹤0.01% | 4077 |
|
|
2021
Q3 | $166K | Buy |
+54,930
| New | +$166K | ﹤0.01% | 4515 |
|